Bain-backed Kailera hopes GLP-1 craze will power IPO through tough market

Atlas Venture, Bain Capital, CPP Investments, RTW Investments and Jiangsu Hengrui Pharmaceuticals have invested $1bn in the company, which makes weight-loss injectables.